Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
about
MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathwayEpithelial membrane protein 2 controls VEGF expression in ARPE-19 cellsVEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis.Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitorsAngiogenesis, cell differentiation and cell survival in tissue engineering and cancer researchEffect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesisDe-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid culturesA novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesisSystemic propranolol reduces b-wave amplitude in the ERG and increases IGF-1 receptor phosphorylation in rat retinaConvergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study.Molecular ultrasound assessment of tumor angiogenesisMathematical models of the VEGF receptor and its role in cancer therapy.Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia.Hepatic artery infusion of antisense oligodeoxynucleotide and lipiodol mixture transfect liver cancer in rats.Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival.Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study.Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer.Pyogenic granuloma complicating pulsed-dye laser therapy for cherry angioma.Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization.Paeonol oxime inhibits bFGF-induced angiogenesis and reduces VEGF levels in fibrosarcoma cellsA human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.The major thoracic vascular invasion of lung cancer.The contribution of a 2-amino group on receptor tyrosine kinase inhibition and antiangiogenic activity in 4-anilinosubstituted pyrrolo[2,3-d]pyrimidinesStimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels.Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signalingMicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGFVascular endothelial growth factors and vascular permeabilityThe influence of fundamental traits on mechanisms controlling appendage regeneration.TM4SF1: a new vascular therapeutic target in cancerCongestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials.Effects of tetrahydrocurcumin on hypoxia-inducible factor-1α and vascular endothelial growth factor expression in cervical cancer cell-induced angiogenesis in nude mice.Inhibition of tumor growth and angiogenesis by soluble EphB4.Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo.Adverse effects of anticancer agents that target the VEGF pathway.Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor
P2860
Q24294441-B10A7666-6651-44D3-8114-42343C283219Q24320319-E6D4236F-85D3-4A3F-8A0B-12B524842C40Q24530176-100A9A54-3DE7-4013-85B3-D362BCB71D47Q24676378-D21F7F21-16A6-444A-AD6A-5BBBDEB60D98Q26778617-D13AB673-C367-48A1-BF98-E12A41858EE0Q28252815-888AAE97-1D34-4968-BA48-29CD14EBBA94Q28277249-BE1A0986-8308-48F3-9832-220C10996299Q28476695-238D7771-EA26-4464-9704-68FB73BDD588Q28854271-736C66AA-5882-4F22-88FB-9EA88C973380Q30417094-682E2534-8EA5-4E63-985C-844B2CC30BD0Q30474770-BBA1F60F-1407-447A-88BD-70A4A3866274Q30481811-2D92665E-CA42-4524-B397-497B6309C3E3Q30784823-414AD6F6-9B83-4580-A810-C047718913F0Q33214070-6CA91C97-2EBC-4644-BE9F-7042D8341FAEQ33305429-87FD6209-0BA1-4704-9820-FE41A3C54F54Q33312494-F04AFB9D-B170-4AA1-BE75-3535319358C4Q33397464-5C91A975-2EFC-489E-8A00-748326BE1F12Q33424102-03D17A85-E421-43AF-8E46-0E4DF1CCADF3Q33435563-6DF12311-F989-492F-9F86-73ADA000A165Q33529769-418F38DA-0815-4025-9FB4-457700F14DE3Q33678987-DB12FAB3-3D44-4F7D-85F0-E1254F5C6B7EQ33680274-DB7DA17D-7213-4575-A74C-BE22316DC14DQ33692521-D77193F9-B4A1-4A63-A3F6-67F5BFBB0CA2Q33705257-83A4C567-87CB-40CF-AC23-6BC14EDE9AA6Q33769561-8FA2CFDA-B0B9-42D2-9C7C-DCB0BB5D6953Q33779432-4CFA31B1-217F-455B-B41A-4CA10CF454A0Q33835552-27A05295-2A4B-41FF-926F-3FF81AADDA5CQ33835807-9842599A-3367-49CB-B696-95430C8474E2Q33854827-41456EB9-536E-4129-AA25-6DCB4FFE0866Q33870715-F86327FC-BE23-440F-83FC-8CE036A53334Q33906023-1ED4675A-E132-410C-9556-FA0146837DC1Q33954958-6CE1CEF0-5DF2-49B9-8DBC-13DB9EE797E5Q34217436-9D1AADC8-C98D-43F6-AFED-545CF44149FAQ34254434-FAE8ABF1-C235-4A97-B9AF-9201D0A70B14Q34554398-329C34B2-B969-4BB9-8A5B-A613CA2B4678Q34668740-6ACA87C8-5503-4EEC-85A9-356508F58C6DQ34770033-1AC1B182-7C52-4275-9BA9-B231EBB82006Q34834369-30EC62DB-B9DA-44FD-9B9C-0D9089ECC3E3Q34990961-908C70A1-5F9F-4688-890A-21ECD9D8A129Q35064517-F030CB8E-97FA-4D03-9DD7-77969D1B2D85
P2860
Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of vascular endothelial g ...... sis: therapeutic implications.
@ast
Role of vascular endothelial g ...... sis: therapeutic implications.
@en
type
label
Role of vascular endothelial g ...... sis: therapeutic implications.
@ast
Role of vascular endothelial g ...... sis: therapeutic implications.
@en
prefLabel
Role of vascular endothelial g ...... sis: therapeutic implications.
@ast
Role of vascular endothelial g ...... sis: therapeutic implications.
@en
P356
P1433
P1476
Role of vascular endothelial g ...... sis: therapeutic implications.
@en
P2093
Napoleone Ferrara
P356
10.1053/SONC.2002.37264
P433
6 Suppl 16
P577
2002-12-01T00:00:00Z